Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes-Reference-Cited by-同舟云学术

Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes

Published:2024-03-01 Issue:3 Volume:26 Page:203-210
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Dunn Timothy C.¹^ORCID,Ajjan Ramzi A.²,Bergenstal Richard M.³^ORCID,Xu Yongjin¹

Affiliation:

1. Clinical Affairs, Abbott Diabetes Care, Alameda, California, USA.

2. The LIGHT Laboratories, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.

3. International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2023.0565

Reference20 articles.

1. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes—2023

2. 6. Glycemic Targets: Standards of Care in Diabetes—2023

3. Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study

4. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

5. Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time above range and no coefficient of variation is associated with diabetic retinopathy in individuals with type 1 diabetes and glycated hemoglobin within target;Acta Diabetologica;2024-08-06

2. Exploring the Continuous Glucose Monitoring in Pediatric Diabetes: Current Practices, Innovative Metrics, and Future Implications;Children;2024-07-27

3. Time in tight range in automated insulin delivery system users: Real‐world data from children and adolescents with type 1 diabetes;Diabetes, Obesity and Metabolism;2024-07-18

4. Prädiktive Faktoren zum Erreichen des engen Glukosezielbereichs;Info Diabetologie;2024-06

5. Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis;Frontiers in Pharmacology;2024-05-30